TENAYA THERAPEUTICS INC (TNYA)
US87990A1060 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 45.68M | 95.30M | 38.10M | 128.50M | 23.90M | |||
| Marketable Securities | 58.96M | 91.30M | 213.20M | 0.00 | 2.80M | |||
| Other Current Assets | 6.94M | 7.20M | 4.10M | 1.40M | 1.10M | |||
| Total Current Assets | 111.58M | 193.80M | 255.40M | 130.00M | 27.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 53.26M | 62.70M | 54.70M | 17.20M | 9.60M | |||
| Investments And Advances | 0.00 | 17.70M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 5.68M | 4.80M | 4.10M | 1.00M | 700.00K | |||
| Total Non-Current Assets | 58.93M | 85.10M | 58.80M | 18.20M | 10.30M | |||
| TOTAL ASSETS | 170.51M | 278.90M | 314.20M | 148.20M | 38.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 16.62M | 14.70M | 10.90M | 3.90M | 2.40M | |||
| Accounts Payable | 5.63M | 9.60M | 10.70M | 1.00M | 600.00K | |||
| Other Current Liabilities | 485.00K | N/A | 200.00K | 100.00K | 1.10M | |||
| Total Current Liabilities | 22.73M | 24.20M | 21.80M | 5.00M | 4.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 8.36M | 11.30M | 13.90M | 3.70M | 4.60M | |||
| Total Non-Current Liabilities | 8.36M | 11.40M | 13.90M | 3.70M | 4.60M | |||
| TOTAL LIABILITIES | 31.09M | 35.60M | 35.70M | 8.70M | 8.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -403.28M | -279.20M | -155.50M | -82.80M | -44.40M | |||
| Additional Paid In Capital | 542.80M | 522.90M | 434.20M | 1.60M | 800.00K | |||
| Common Shares | 7.00K | 0.00 | 0.00 | 220.80M | 73.00M | |||
| Other Shareholders' Equity | -106.00K | -400.00K | -100.00K | -100.00K | -100.00K | |||
| Shares Outstanding | 68.33M | 66.90M | 41.30M | 39.30M | 39.30M | |||
| Tangible Book Value per Share | 2.04 | 3.64 | 6.74 | -2.07 | -1.11 | |||
| Total Shareholders' Equity | 139.42M | 243.40M | 278.50M | 139.40M | 29.30M | |||
| TOTAL LIABILITIES AND EQUITY | 170.51M | 278.90M | 314.20M | 148.20M | 38.00M | |||
| Statistics | ||||||||
| Current Ratio | 4.91 | 8.01 | 11.72 | 26.00 | 6.76 | |||
| Return On Assets (ROA) | -72.77% | -44.34% | -23.14% | -25.91% | -69.03% | |||
| Return On Equity (ROE) | -89.00% | -50.81% | -26.11% | -27.55% | -89.52% | |||
All data in USD